News
Hosted on MSN9mon
Diabetic Attacks and Emergencies - MSNDiabetic ketoacidosis and hypoglycemia are more likely to cause a diabetic coma in those with type 1 diabetes, while HHS places people with type 2 diabetes more at risk of this condition.
The most common acute complications of T2D are metabolic problems (DKA, HHS, hypoglycemia) and infection. In addition, the quality of life of patients with acute complications is adversely ...
3d
MedPage Today on MSNOzempic Shows Benefit in Type 1 Diabetes Patients With ObesityCHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
Learn to recognize and respond to diabetic emergencies like hypoglycemia, DKA, HHS, and preeclampsia. Discover first aid steps to help someone in a diabetes crisis.
4mon
Everyday Health on MSNWhat’s the Difference Between Ketosis and Diabetic Ketoacidosis? - MSNKetosis and ketoacidosis may sound similar, but ketosis is a fat-burning metabolic state, while diabetic ketoacidosis is a life-threatening complication of diabetes. Ketones in the body trigger ...
Hybrid closed-loop insulin pumps improve time in range, but increase ketoacidosis - News-Medical.net
Researchers have therefore now investigated whether the rates of severe low blood sugar levels (hypoglycemia) and diabetic ketoacidosis are lower with hybrid closed-loop insulin therapy compared ...
Panelists discuss how type 1 diabetes is diagnosed using autoantibody testing and the challenges clinicians face, including the common misdiagnosis of adults with type 1 diabetes as having type 2 ...
Hypoglycemia: When there’s too little sugar On the flip side, hypoglycemia can also lead to a diabetic coma. This occurs when blood sugar levels drop too low, typically below 70 mg/dL.
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2–20 years) with type 1 diabetes: a population-based study.
Lexicon (LXRX) announced the peer-reviewed Journal of American Society of Nephrology, or JASN, has published a research paper analyzing the efficacy and safety of sotagliflozin, a dual SGLT1 and ...
Published Data in Journal of American Society of Nephrology Highlights Findings on Efficacy and Safety of Sotagliflozin for People With Type 1 Diabetes and Chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results